This trial will compare the effects of intrapartum nipple stimulation versus exogenous oxytocin infusion for nulliparous women undergoing induction of labor near term. The primary hypothesis is that intrapartum nipple stimulation to induce labor increases spontaneous vaginal delivery.
- Physiological Effects of Drugs
- Labor Pain
- Induction of Labor
1 Primary · 9 Secondary · Reporting Duration: up to 28 days following delivery
2 Treatment Groups
Exogenous oxytocin intravenous infusion
1 of 2
Intrapartum nipple stimulation
1 of 2
562 Total Participants · 2 Treatment Groups
Primary Treatment: Electric breast pump · No Placebo Group · Phase 4
Who is running the clinical trial?
Age 18+ · Female Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Has the Electric breast pump met all safety criteria established by the FDA?
"Our team estimates the safety of electric breast pumps to be a 3, as Phase 4 trials denote that this method has already been approved." - Anonymous Online Contributor
Is enrollment in the trial still accepting participants?
"As per clinicaltrials.gov, this trial is still accepting patients for participation. It was first advertised on November 15th 2021 and more recently updated on January 24th 2022." - Anonymous Online Contributor
In what instances does a healthcare provider commonly recommend an electric breast pump?
"Electric breast pumps can assist with managing hemorrhaging, childbirth, and uterine contraction." - Anonymous Online Contributor
How many subjects are enrolled in this trial?
"Affirmative. According to the clinicaltrials.gov website, this research trial is open for recruitment and began on November 15th 2021 before being updated most recently on January 24th 2022. It requires 562 participants from a single medical centre." - Anonymous Online Contributor